Toxicokinetics of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in two substrains of male Long-Evans rats after intravenous injection

Fundamental and Applied Toxicology

Volumn 31, Issue 2, 1996, Pages 184-191

  Viluksela, Matti ^a,b   Duong, Thang V ^a   Stahl, Bernhard U ^a,c   Li, Xuelin ^a   Tuomisto, Jouko ^b   Rozman, Karl K ^a,c  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN;

ADRENAL GLAND; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; BODY WEIGHT; BROWN ADIPOSE TISSUE; CONTROLLED STUDY; DRUG EXCRETION; DRUG SENSITIVITY; FECES; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; MALE; MORTALITY; NONHUMAN; QUANTITATIVE HISTOCHEMISTRY; RAT; STRAIN DIFFERENCE; THYMUS; TOXICOKINETICS; URINARY EXCRETION; WHITE ADIPOSE TISSUE;

ANIMALIA; RODENTIA;

EID: 26844437748     PISSN: 02720590     EISSN: None     Source Type: Journal    
DOI: 10.1006/faat.1996.0090     Document Type: Article

References (17)

1. Beatty, P. W., Vaughn, W. K., and Neal, R. A. (1978). Effect of alteration of rat hepatic mixed-function oxidase (MFO) activity on the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicol. Appl. Pharmacol. 45, 513-519.
2. Fan, F., and Rozman, K. (1994). Relationship between acute toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and disturbance of intermediary metabolism in the Long-Evans rat. Arch. Toxicol. 69, 73-78.
3. Goldstein, J. A., and Linko, P. (1984). Differential induction of two 2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible forms of cytochrome P450 in extrahepatic versus hepatic tissues. Mol. Pharmacol. 25, 185-191.
4. Gorski, J. R., Muzi, G., Weber, L. W. D., Pereira, D. W., Arceo, R. J., Iatropoulos, M. J., and Rozman, K. (1988). Some endocrine and morphological aspects of the acute toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicol. Pathol. 16, 313-320.
5. Gupta, B. N., Vos, J. G., Moore, J. A., Zinkl, J. G., and Bullock, B. C. (1973). Pathologic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin in laboratory animals. Environ. Health Perspect. 5, 125-140.
6. Kociba, R. J., Keeler, P. A., Park, C. N., and Gehring, P. J. (1976). 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD): Results of a 13-week oral toxicity study in rats. Toxicol. Appl. Pharmacol. 35, 553-574.
7. Kociba, R. J., Keyes, D. G., Beyer, J. E., Carreon, R. M., Wade, C. E., and Dittenber, D. A. (1978). Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats. Toxicol. Appl. Pharmacol. 46, 279-303.
8. Li, X., Weber, L. W. D., and Rozman, K. K. (1995). Toxicokinetics of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in female Sprague-Dawley rats including placental and lactational transfer to fetuses and neonates. Fundam. Appl. Toxicol. 27, 70-76.
9. Neal, R. A., Olson, J. R., Gasiewicz, T. A., and Geiger, L. E. (1982). The toxicokinetics of 2,3,7,8-tetrachlorodibenzo-p-dioxin in mammalian systems. Drug Metab. Rev. 13, 355-385.
10. Pohjanvirta, R., Unkila, M., and Tuomisto, J. (1993). Comparative acute lethality of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), 1,2,3,7,8-pentachlorodibenzo-p-dioxin and 1,2,3,4,7,8-hexachlorodibenzo-p-dioxin in the most TCDD susceptible and the most TCDD resistant rat strain. Pharmacol. Toxicol. 73, 52-56.
11. Pohjanvirta, R., Vartiainen, T., Uusi-Rauva, A., Mönkkönen, J., and Tuomisto, J. (1990). Tissue distribution, metabolisms, and excretion of 14C-TCDD in a TCDD-susceptible and a TCDD-resistant rat strain. Pharmacol. Toxicol. 66, 93-100.
12. Rozman, K., Pereira, D., and Iatropoulos, M. J. (1986). Histopathology of interscapular brown adipose tissue, thyroid, and pancreas in 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-treated rats. Toxicol. Appl. Pharmacol. 82, 551-559.
13. Schwetz, B. A., Norris, J. M., Sparschu, G. L., Rowe, V. K., Gehring, P. J., Emerson, J. L., and Gebrig, C. G. (1973). Toxicology of chlorinated dibenzo-p-dioxins. Environ. Health Perspect. 5, 87-99.
14. Stahl, B. U., Kettrup, A., and Rozman, K. (1992). Comparative toxicity of four chlorinated dibenzo-p-dioxins (CDDs) and their mixture. Part I: Acute toxicity and toxic equivalent factors (TEFs). Arch. Toxicol. 66, 471-477.
15. Tuomisto, J., Andrzejewski, W., Unkila, M., Pohjanvirta, R., Linden, J., Vartiainen, T., and Tuomisto, L. (1995). Modulation of TCDD-induced wasting syndrome by portocaval anastomosis and vagotomy in Long-Evans and Han/Wistar rats. Eur. J. Pharmacol. 292, 277-285.
16. Van den Berg, M., De Jongh, J., Poiger, H., and Olson, J. R. (1994). The toxicokinetics and metabolism of polychlorinated dibenzo-p-dioxins (PCDDs) and dibenzofurans (PCDFs) and their relevance for toxicity. Crit. Rev. Toxicol. 24, 1-74.
17. Weber, L. W. D., Ernst, S. W., Stahl, B. U., and Rozman, K. (1993). Tissue distribution and toxicokinetics of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats after intravenous injection. Fundam. Appl. Toxicol. 21, 523-534.